Congenital Plasminogen Deficiency Latest Advances

Plain language summary: a phase 2/3 study of plasminogen, human-tvmh for the treatment of children and adults with type 1 plasminogen deficiency.

Journal: Expert review of hematology

Published: June 02, 2026

Plain language summary: How safe and effective is long-term treatment with intravenous plasminogen concentrate for people with type 1 plasminogen deficiency?

Journal: Therapeutic advances in hematology

Published: February 23, 2026

Sex- and stressor-dependent effects of metformin on cardiac fibrosis in plasminogen activator inhibitor-1 deficiency.

Journal: Journal of molecular and cellular cardiology

Published: February 13, 2026

Compound heterozygous plasminogen mutations causing hereditary plasminogen deficiency: a family study and mechanistic analysis

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: February 09, 2026

Urokinase Plasminogen Activator Deficiency Delays the Development of Obesity and Metabolic Sequelae.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: January 22, 2026

Sustained Therapeutic Efficacy of Intravenous Plasminogen Concentrate in Pediatric Patients With Type 1 Plasminogen Deficiency: An Analysis of Dosing Parameters and Clinical Outcomes.

Journal: Pediatric blood & cancer

Published: December 23, 2025

Genotype-Phenotype Correlation of Hereditary Plasminogen Deficiency: Molecular Mechanisms From 18 Patients With Cerebral Infarction.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: October 25, 2025

Congenital Holoprocencephaly, Hydrocephalus, and Dandy-Walker Malformation Due to Plasminogen Deficiency.

Journal: Cureus

Published: October 07, 2025

Human plasma-derived plasminogen replacement in type 1 plasminogen deficiency: a pediatric case with multisystemic manifestation.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: September 07, 2025

Fresh frozen plasma therapy in type I plasminogen deficiency: a case of ligneous conjunctivitis with hydrocephalus.

Journal: Oxford medical case reports

Published: August 24, 2025

Lung Involvement in a Child With Type 1 Plasminogen Deficiency.

Journal: Pediatric pulmonology

Published: June 27, 2025

Novel compound heterozygous mutations in plasminogen (p.Gly568Arg/p.Ala620Thr) impair protein structure and function in type II deficiency: mechanistic insights into a hereditary thrombogenic disorder.

Journal: Orphanet journal of rare diseases

Published: June 26, 2025

Congenital Plasminogen Deficiency Latest Advances

Find the Latest Research About Congenital Plasminogen Deficiency

Plain language summary: a phase 2/3 study of plasminogen, human-tvmh for the treatment of children and adults with type 1 plasminogen deficiency.

Plain language summary: a phase 2/3 study of plasminogen, human-tvmh for the treatment of children and adults with type 1 plasminogen deficiency.

Plain language summary: How safe and effective is long-term treatment with intravenous plasminogen concentrate for people with type 1 plasminogen deficiency?

Plain language summary: How safe and effective is long-term treatment with intravenous plasminogen concentrate for people with type 1 plasminogen deficiency?

Sex- and stressor-dependent effects of metformin on cardiac fibrosis in plasminogen activator inhibitor-1 deficiency.

Sex- and stressor-dependent effects of metformin on cardiac fibrosis in plasminogen activator inhibitor-1 deficiency.

Compound heterozygous plasminogen mutations causing hereditary plasminogen deficiency: a family study and mechanistic analysis

Compound heterozygous plasminogen mutations causing hereditary plasminogen deficiency: a family study and mechanistic analysis

Urokinase Plasminogen Activator Deficiency Delays the Development of Obesity and Metabolic Sequelae.

Urokinase Plasminogen Activator Deficiency Delays the Development of Obesity and Metabolic Sequelae.

Sustained Therapeutic Efficacy of Intravenous Plasminogen Concentrate in Pediatric Patients With Type 1 Plasminogen Deficiency: An Analysis of Dosing Parameters and Clinical Outcomes.

Sustained Therapeutic Efficacy of Intravenous Plasminogen Concentrate in Pediatric Patients With Type 1 Plasminogen Deficiency: An Analysis of Dosing Parameters and Clinical Outcomes.

Genotype-Phenotype Correlation of Hereditary Plasminogen Deficiency: Molecular Mechanisms From 18 Patients With Cerebral Infarction.

Genotype-Phenotype Correlation of Hereditary Plasminogen Deficiency: Molecular Mechanisms From 18 Patients With Cerebral Infarction.

Congenital Holoprocencephaly, Hydrocephalus, and Dandy-Walker Malformation Due to Plasminogen Deficiency.

Congenital Holoprocencephaly, Hydrocephalus, and Dandy-Walker Malformation Due to Plasminogen Deficiency.

Human plasma-derived plasminogen replacement in type 1 plasminogen deficiency: a pediatric case with multisystemic manifestation.

Human plasma-derived plasminogen replacement in type 1 plasminogen deficiency: a pediatric case with multisystemic manifestation.

Fresh frozen plasma therapy in type I plasminogen deficiency: a case of ligneous conjunctivitis with hydrocephalus.

Fresh frozen plasma therapy in type I plasminogen deficiency: a case of ligneous conjunctivitis with hydrocephalus.

Lung Involvement in a Child With Type 1 Plasminogen Deficiency.

Lung Involvement in a Child With Type 1 Plasminogen Deficiency.

Novel compound heterozygous mutations in plasminogen (p.Gly568Arg/p.Ala620Thr) impair protein structure and function in type II deficiency: mechanistic insights into a hereditary thrombogenic disorder.

Novel compound heterozygous mutations in plasminogen (p.Gly568Arg/p.Ala620Thr) impair protein structure and function in type II deficiency: mechanistic insights into a hereditary thrombogenic disorder.